Targeting histone deacetylase 11 (HDAC11) represents a promising therapeutic strategy, yet developing selective inhibitors for solid tumors remains a formidable challenge. Herein, we describe the rational lead optimization of a novel series of indole-based hydroxamic acids. Guided by our previous lead PB94, a systema...
Xin-Yu Yang, Xin Li, Rui Huang et al.· Journal of Medicinal Chemist...· 0 citations
A novel PET tracer, [18F]XW-032, was developed via ruthenium-mediated deoxyfluorination and effectively visualized regional IDO1 heterogeneity in the AD brain, positioning it as a potent molecular tool for early AD diagnosis and for monitoring the efficacy of IDO1-targeted therapeutic interventions.
Hua Cheng, Nilay S. Narayan, Yong-Le Wang et al.· Materials Today Bio· 0 citations
It is proposed that translational control of the iron-homeostatic protein α-synuclein (iron importer) could therapeutically normalize subcortical iron during PD progression.
Jack T. Rogers, Asif Mirza Maroof, Sanjan S. Sarang et al.· Journal of Alzheimer's Disea...· 0 citations
Treatment of AD patient-derived hiPSC glia cells including microglia and astrocytes and neuropathic pain mice with 22 led to suppression of NLRP3 expression and decreased pain and pain-like behavior, supporting the translational promise of this compound and analogs from this chemotype.
Yi-Ming Xu, J. Namme, Liuyue Yang et al.· European journal of medicina...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.